1. Genome characterization of Hirame novirhabdovirus (HIRRV) isolate CNPo2015 and transcriptome analysis of Hirame natural embryo (HINAE) cells infected with CNPo2015
   Fenghuang Pan et al, 2023, Fish & Shellfish Immunology CrossRef
2. Contrasting academic and lay press print coverage of the 2013-2016 Ebola Virus Disease outbreak
   Mark D. Kieh et al, 2017, PLOS ONE CrossRef
3. Transcriptome-wide N6-methyladenosine modification profiling of mRNAs during infection of Newcastle disease virus in chicken macrophages
   Jindou Li et al, 2023, Virus Research CrossRef
4. Genetic variants in IFIH1 and DDX58 influence hepatitis C virus clearance in Chinese Han population
   Xiao‐Bo Zhu et al, 2019, Journal of Medical Virology CrossRef
5. Type I and Type II Interferon Antagonism Strategies Used by Paramyxoviridae: Previous and New Discoveries, in Comparison
   Giuseppe Pisanelli et al, 2022, Viruses CrossRef
6. Mitochondria at Work: New Insights into Regulation and Dysregulation of Cellular Energy Supply and Metabolism
   Volker Schirrmacher, 2020, Biomedicines CrossRef
7. Exosomes Carry microRNAs into Neighboring Cells to Promote Diffusive Infection of Newcastle Disease Virus
   Changluan Zhou et al, 2019, Viruses CrossRef
8. Oncolytic viral vectors in the era of diversified cancer therapy: from preclinical to clinical
   Chao Tang et al, 2022, Clinical and Translational Oncology CrossRef
9. HIV-1 Vpr antagonizes innate immune activation by targeting karyopherin-mediated NF-κB/IRF3 nuclear transport
   Hataf Khan et al, 2020, eLife CrossRef
10. The role of immunogenic clinical death in the virotherapy of malignant neoplasms
    A.Y. Gavrilov et al, 2021, Experimental and Clinical Medicine CrossRef
11. Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy
    Volker Schirrmacher et al, 2022, International Journal of Molecular Sciences CrossRef
12. Robust Lys63-Linked Ubiquitination of RIG-I Promotes Cytokine Eruption in Early Influenza B Virus Infection
    Jingwen Jiang et al, 2016, Journal of Virology CrossRef
13. Pathologic Mechanisms of the Newcastle Disease Virus
    Di Zhang et al, 2023, Viruses CrossRef
14. IFI16 is required for DNA sensing in human macrophages by promoting production and function of cGAMP
    K. L. Jønsson et al, 2017, Nature Communications CrossRef
15. Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus
    Volker Schirrmacher, 2022, Biomedicines CrossRef
16. The matrix protein of Newcastle disease virus inhibits inflammatory response through IRAK4/TRAF6/TAK1/NF-κB signaling pathway
    Zhiqiang Duan et al, 2022, International Journal of Biological Macromolecules CrossRef
17. Oncolytic Viruses as Immunotherapeutic Agents
    Yevhenii Trehub et al, 2021, Cancer Immunology CrossRef
18. Oncolytic Virotherapy in Glioma Tumors
    Sergio Rius-Rocabert et al, 2020, International Journal of Molecular Sciences CrossRef
19. Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients
    Volker Schirrmacher, 2017, International Journal of Molecular Sciences CrossRef
20. Patterns of RNA Editing in Newcastle Disease Virus Infections
    Archana Jadhav et al, 2020, Viruses CrossRef
21. Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy
    Zahra Fekrirad et al, 2022, Cancers CrossRef
22. Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy
    null Schirrmacher et al, 2019, Biomedicines CrossRef
23. Fludarabine as an Adjuvant Improves Newcastle Disease Virus-Mediated Antitumor Immunity in Hepatocellular Carcinoma
    Gang Meng et al, 2019, Molecular Therapy - Oncolytics CrossRef
24. Thymic transcriptome analysis after Newcastle disease virus inoculation in chickens and the influence of host small RNAs on NDV replication
    Liangxing Guo et al, 2021, Scientific Reports CrossRef